MS-Selfie
Subscribe
Sign in
Home
Notes
MS-Selfie Research
MS-Selfie Microsite
Contact
Q&A
Archive
Leaderboard
About
Q&A 143 - ACTRIMS 2026: BTK inhibition in PPMS
“MS at a Crossroads” - a new treatment for Primary Progressive Multiple Sclerosis
9 hrs ago
•
Gavin Giovannoni
9
14
Latest
Top
Discussions
Research News #1
I am launching a new MS-Selfie feature called “Research News” in which I will review research papers that have caught my attention over the last week or…
Feb 5
•
Gavin Giovannoni
28
24
1
What is an MS label?
These MS labels have now become sticky and inform clinical practice. What label best describes your MS?
Feb 4
•
Gavin Giovannoni
12
44
Q&A 142: Epsilon toxin and MS
One hypothesis I have spent less time discussing is the so-called ‘dual-hit’ hypothesis, i.e. EBV sets the stage for another factor such as a toxin to…
Feb 3
•
Gavin Giovannoni
9
22
2
Should I be worried about measles?
Do you know your MMR status? If not, you may want to know particularly if you are about to start an immunosuppressive therapy.
Jan 29
•
Gavin Giovannoni
11
23
8:44
Q&A 141: neutropaenia on ocrelizumab
Have any of you developed low neutrophil counts on ocrelizumab or the other anti-CD20 therapies? Did it resolve and/or recur? How was it managed? Did…
Jan 27
•
Gavin Giovannoni
9
16
10:30
Tolebrutinib treatment algorithm 2.0
The aim of the diagram is to demonstrate how complex things become when you start to divide non-relapsing SPMS into subgroups.
Jan 27
•
Gavin Giovannoni
8
4
Proposed tolebrutinib treatment algorithm
Does the figure make sense to you? If you have or may have SPMS, could you navigate the algorithm? Thanks.
Jan 26
•
Gavin Giovannoni
6
28
See all
MS-Selfie
MS-Selfie helps you self-manage your multiple sclerosis. MS-Selfie consists of the newsletter and the MS-Selfie microsite, which consists of curated content https://msselfie.co.uk/
Subscribe
MS-Selfie
Subscribe
About
Archive
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts